Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Scientists can mimic hair disorders by altering genes in lab-grown human hair follicles, but these follicles lack some features of natural ones.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Using body measurements can help achieve good results in plastic surgery like reshaping the torso, but it doesn't work for all body types.

The 3D skin model mimics pemphigus vulgaris and helps test treatments.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Hair growth cycles in Chileans vary seasonally, with more hair resting in summer and growing in winter.

The patient with lupus and hair loss improved with oral and topical minoxidil.

Media images promote unrealistic beauty standards, affecting body image and eating disorders globally.

Use ethical and humane practices in mouse research.

Stump-tailed macaque best for researching hair loss causes and treatments.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

The EMG-to-force model accurately predicts hip muscle forces during walking.

Large language models often give biased or inaccurate medical responses, especially for LGBTQIA+ prompts.

Transplant success has improved with better immunosuppressive drugs and donor matching.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cetuximab can cause eyelash growth, which is rare but manageable.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

New treatments for lupus show promise, but more research is needed, especially for children.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

Biologics for severe asthma have known side effects, but some new risks need more study.